Huber Capital Management LLC Sells 11,012 Shares of Utah Medical Products, Inc. $UTMD

Huber Capital Management LLC lessened its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 23.0% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 36,840 shares of the medical instruments supplier’s stock after selling 11,012 shares during the period. Huber Capital Management LLC owned 1.15% of Utah Medical Products worth $2,062,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Segall Bryant & Hamill LLC bought a new stake in Utah Medical Products during the third quarter valued at about $726,000. Brandes Investment Partners LP grew its holdings in Utah Medical Products by 4.0% during the fourth quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock valued at $19,660,000 after purchasing an additional 13,392 shares during the period. Comerica Bank grew its holdings in Utah Medical Products by 435.6% during the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 440 shares during the period. BNP Paribas Financial Markets grew its holdings in Utah Medical Products by 89.6% during the third quarter. BNP Paribas Financial Markets now owns 1,060 shares of the medical instruments supplier’s stock valued at $67,000 after purchasing an additional 501 shares during the period. Finally, Russell Investments Group Ltd. grew its holdings in Utah Medical Products by 47.1% during the third quarter. Russell Investments Group Ltd. now owns 4,057 shares of the medical instruments supplier’s stock valued at $255,000 after purchasing an additional 1,299 shares during the period. Institutional investors own 69.60% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “hold (c-)” rating on shares of Utah Medical Products in a research report on Friday, May 22nd. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Utah Medical Products Stock Down 2.3%

Shares of Utah Medical Products stock opened at $67.84 on Friday. The stock’s 50-day simple moving average is $66.09 and its 200-day simple moving average is $62.73. Utah Medical Products, Inc. has a 52 week low of $52.00 and a 52 week high of $71.81. The company has a market capitalization of $215.73 million, a price-to-earnings ratio of 20.07 and a beta of 0.37.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings data on Thursday, April 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. Utah Medical Products had a return on equity of 9.13% and a net margin of 28.90%.The business had revenue of $8.72 million for the quarter.

Utah Medical Products Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 3rd. Stockholders of record on Wednesday, June 17th will be given a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Wednesday, June 17th. Utah Medical Products’s payout ratio is presently 36.69%.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).